| Author/Editor | Štalc, Monika; Poredoš, Pavel; Peternel, Polona; Tomšič, Matija; Šebeštjen, Miran; Kveder, Tanja | |
| Title | Endothelial function is impaired in patients with primary antiphospholipid syndrome | |
| Type | članek | |
| Source | Thromb Res Suppl | |
| Vol. and No. | Letnik 118, št. 4 | |
| Publication year | 2006 | |
| Volume | str. 455-61 | |
| Language | eng | |
| Abstract | INTRODUCTION: The aim of this study was to evaluate endothelial function in patients with primary antiphospholipid syndrome (PAPS). PATIENTS AND METHODS: Flow mediated (FMD) and glyceryl trinitrate (GTN) induced dilation of the right brachial artery were studied in 25 patients with PAPS and 25 controls matched by age, sex and conventional risk factors for atherosclerosis. Fibrinogen, D-dimer, adhesion molecules, tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) antigens and activities were measured. RESULTS: Mean (SD) FMD was significantly lower in PAPS than in controls (8+/-5% vs. 15+/-6%, P<0.001); GTN-induced dilation did not differ between the groups. There was a correlation between the baseline diameter of the brachial artery and duration of the disease (-0.56, P<0.05) and between GTN induced dilation and duration of the disease (0.51, P<0.05). Concentrations of vascular cell adhesion molecule-1 (P<0.001), intracellular adhesion molecule-1 (P<0.001) and fibrinogen (P<0.05) were higher in patients than in controls but no differences were observed for D-dimer, t-PA and PAI-1 antigens and activities. There was correlation between concentration of vascular cell adhesion molecule-1 and FMD (-0.35, P<0.05) and between intracellular adhesion molecule-1 and FMD (-0.41, P<0.05). CONCLUSIONS: This study shows that endothelial function is impaired in patients with primary APS, possibly contributing to accelerated atherosclerosis and thromboembolic complications in these patients. | |
| Descriptors | ANTIPHOSPHOLIPID SYNDROME ENDOTHELIUM, VASCULAR BRACHIAL ARTERY NITROGLYCERIN VASODILATION ATHEROSCLEROSIS FIBRINOGEN PLASMINOGEN ACTIVATOR INHIBITOR 1 VASCULAR CELL ADHESION MOLECULE-1 INTERCELLULAR ADHESION MOLECULE-1 |